136 related articles for article (PubMed ID: 2450706)
1. Differential expression of MHC class II antigens in chronic B-cell disorders.
Drexler HG; Gignac SM; Brenner MK; Coustan-Smith E; Janossy G; Hoffbrand AV
Clin Exp Immunol; 1988 Feb; 71(2):217-23. PubMed ID: 2450706
[TBL] [Abstract][Full Text] [Related]
2. Expression of MHC class II antigens in human B-cell leukaemia, and increased levels of class II antigens and DR-specific mRNA after stimulation with 12-O-tetradecanoyl phorbol-13-acetate.
Guy K; Meehan RR; Dewar AE; Larhammar D
Immunology; 1986 Feb; 57(2):181-8. PubMed ID: 3512424
[TBL] [Abstract][Full Text] [Related]
3. Expression of MHC class II antigens in human B-cell leukaemia and non-Hodgkin's lymphoma.
Guy K; Krajewski AS; Dewar AE
Br J Cancer; 1986 Feb; 53(2):161-73. PubMed ID: 3513812
[TBL] [Abstract][Full Text] [Related]
4. Deficient expression of MHC class II antigens in some cases of human B cell leukaemia.
Guy K; Docherty LJ; Dewar AE
Clin Exp Immunol; 1986 Feb; 63(2):290-7. PubMed ID: 3486060
[TBL] [Abstract][Full Text] [Related]
5. HLA-DP can be expressed with or without -DR molecules on a malignant B cell line.
Pesando JM; Graf L; Hoffman P
J Immunol; 1986 Sep; 137(6):1932-6. PubMed ID: 3489045
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells.
Pesando JM; Graf L
J Immunol; 1986 Jun; 136(11):4311-8. PubMed ID: 2939141
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies to sheep MHC class II molecules recognize all HLA-D or subsets of HLA-D region products.
Puri NK; de Kretser T; Brandon MR
Hum Immunol; 1987 Nov; 20(3):195-207. PubMed ID: 3501780
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
[TBL] [Abstract][Full Text] [Related]
9. Antibodies reactive with class II antigens encoded for by the major histocompatibility complex inhibit human B cell activation.
Clement LT; Tedder TF; Gartland GL
J Immunol; 1986 Apr; 136(7):2375-81. PubMed ID: 3485149
[TBL] [Abstract][Full Text] [Related]
10. Ontogenic and functional implications of the differential expression of HLA-DQ antigens on leukemic cells.
Navarrete C; Fernandez N; Alonso MC; Festenstein H
Hum Immunol; 1986 May; 16(1):52-68. PubMed ID: 3519548
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
[TBL] [Abstract][Full Text] [Related]
12. B-lymphocyte associated differentiation antigen expression by 'non-B, non-T' acute lymphoblastic leukemia.
Flug F; Dodson L; Wolff J; Guarini L; Rausen A; Wang CY; Knowles DM
Leuk Res; 1985; 9(8):1051-8. PubMed ID: 2931557
[TBL] [Abstract][Full Text] [Related]
13. Leu-10 (HLA-DC/DS) antigen distribution in human leukaemic disorders as detected by a monoclonal antibody: correlation with HLA-DR expression.
Al-Katib A; Koziner B
Br J Haematol; 1984 Jul; 57(3):373-82. PubMed ID: 6378248
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of HLA-DR and HLA-DC/DS molecules in a patient with hairy cell leukemia: restoration of HLA-DC/DS expression by (12-0-tetradecanoyl phorbol-13-acetate), 5 azacytidine, and sodium butyrate.
Faille A; Turmel P; Charron DJ
Blood; 1984 Jul; 64(1):33-7. PubMed ID: 6203577
[TBL] [Abstract][Full Text] [Related]
15. CDw78--a determinant on a major histocompatibility complex class II subpopulation that can be induced to associate with the cytoskeleton.
Rasmussen AM; Horejsí V; Levy FO; Blomhoff HK; Smeland EB; Beiske K; Michaelsen TE; Gaudernack G; Funderud S
Eur J Immunol; 1997 Dec; 27(12):3206-13. PubMed ID: 9464807
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of surface antigens with appearance of HLA class II molecules on a malignant human B-cell line.
Pesando JM; Stucki M; Hoffman P
Hum Immunol; 1987 Aug; 19(4):235-43. PubMed ID: 3316133
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the expression of HLA class II antigens by gamma interferon and phorbol ester TPA on myeloid leukaemic cell lines.
Alonso MC; Navarrete C; Solana R; Ramirez R; Peña J; Festenstein H
J Immunogenet; 1986; 13(2-3):255-61. PubMed ID: 3102618
[TBL] [Abstract][Full Text] [Related]
18. T cells specific for different antigens express different HLA-D region products.
Schendel DJ; Johnson JP
Eur J Immunol; 1985 Dec; 15(12):1239-43. PubMed ID: 3878791
[TBL] [Abstract][Full Text] [Related]
19. Ligation of MHC class II molecules differentially upregulates TNF beta gene expression in B cell lines of different MHC class II haplotypes.
Guo W; Mourad W; Charron D; Al-Daccak R
Hum Immunol; 1999 Apr; 60(4):312-22. PubMed ID: 10363722
[TBL] [Abstract][Full Text] [Related]
20. HLA-DR and DQ antigens in chronic lymphocytic leukemia: dissociation of expression revealed by cell surface, protein, and mRNA studies.
Kraïba R; Loiseau P; Faille A; Poirier O; Piatier-Tonneau D; Degos L; Abita JP; Charron D
Leukemia; 1989 May; 3(5):386-93. PubMed ID: 2497283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
